Found: 12
Select item for more details and to access through your institution.
Follow-up after Direct-acting Antiviral Treatment for Chronic Hepatitis C Virus Infection: Most Patients Are Followed Appropriately.
- Published in:
- Internal Medicine, 2021, v. 60, n. 19, p. 3061, doi. 10.2169/internalmedicine.6591-20
- By:
- Publication type:
- Article
Real‐world efficacy and safety of 12‐week sofosbuvir/velpatasvir treatment for patients with decompensated liver cirrhosis caused by hepatitis C virus infection.
- Published in:
- Hepatology Research, 2021, v. 51, n. 1, p. 51, doi. 10.1111/hepr.13576
- By:
- Publication type:
- Article
Favorable outcome of retreatment by direct‐acting antivirals for hepatitis C patients with daclatasvir plus asunaprevir combination therapy failure.
- Published in:
- Hepatology Research, 2020, v. 50, n. 3, p. 303, doi. 10.1111/hepr.13462
- By:
- Publication type:
- Article
Analyses of objective response rate, progression‐free survival, and adverse events in hepatocellular carcinoma patients treated with lenvatinib: A multicenter retrospective study.
- Published in:
- Hepatology Research, 2020, v. 50, n. 3, p. 382, doi. 10.1111/hepr.13460
- By:
- Publication type:
- Article
Clinical and virological features of acute hepatitis E in Gunma prefecture, Japan between 2004 and 2015.
- Published in:
- Hepatology Research, 2017, v. 47, n. 5, p. 435, doi. 10.1111/hepr.12765
- By:
- Publication type:
- Article
Expression of amino acid transporters ( LAT1, ASCT2 and xCT) as clinical significance in hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2015, v. 45, n. 9, p. 1014, doi. 10.1111/hepr.12431
- By:
- Publication type:
- Article
Liver Function Changes in Patients with Hepatocellular Carcinoma Treated with Lenvatinib: Predictive Factors of Progression to Child-Pugh Class B, the Formation of Ascites and the Candidates for the Post-Progression Treatment.
- Published in:
- Cancers, 2020, v. 12, n. 10, p. 2906, doi. 10.3390/cancers12102906
- By:
- Publication type:
- Article
Gastric Ulcer Bleeding from a Variant Left Gastric Artery Accompanied by Congenital Absence of the Splenic Artery Successfully Treated With Coil Embolization: a Case Report and Review of the Literature.
- Published in:
- 2011
- By:
- Publication type:
- Case Study
Lenvatinib for Hepatocellular Carcinoma Patients with Nonviral Infection Who Were Unlikely to Respond to Immunotherapy: A Retrospective, Comparative Study.
- Published in:
- Oncology, 2021, v. 99, n. 10, p. 641, doi. 10.1159/000517494
- By:
- Publication type:
- Article
The Role of the Albumin-Bilirubin Score for Predicting the Outcomes in Japanese Patients with Advanced Hepatocellular Carcinoma Treated with Ramucirumab: A Real-World Study.
- Published in:
- Oncology, 2021, v. 99, n. 4, p. 203, doi. 10.1159/000511734
- By:
- Publication type:
- Article
The Treatment Effects of Percutaneous Drainage with or without Sclerotherapy for Symptomatic Liver Cysts.
- Published in:
- Gastrointestinal Disorders, 2024, v. 6, n. 1, p. 13, doi. 10.3390/gidisord6010002
- By:
- Publication type:
- Article
Optimal follow-up time to determine the sustained virological response in patients with chronic hepatitis C receiving pegylated-interferon and ribavirin.
- Published in:
- Journal of Gastroenterology & Hepatology, 2012, v. 27, n. 1, p. 69, doi. 10.1111/j.1440-1746.2011.06802.x
- By:
- Publication type:
- Article